Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: Key predictors of long-term outcomes in BCMA-targeted CAR-T therapy for relapsed/refractory multiple myeloma

Fig. 4

Treatment Duration Relative to MRD Dynamics. Each row represents an individual patient categorized by the durability of MRD status. Annotations include cytogenetic data, patient disposition, and best response achieved. In the MRD-positive group, patients with progressive disease did not undergo MRD testing. CR, complete response; MR, minimal response; MRD, minimal residual disease; PR, partial response; SD, stable disease; sCR, stringent complete response; VGPR, very good partial response

Back to article page